摘要
妊娠滋养细胞疾病是来源于胎盘滋养细胞的一组疾病,包括葡萄胎,侵蚀性葡萄胎,绒毛膜癌,胎盘部位滋养细胞肿瘤,是对女性健康带来严重威胁的疾病之一。其发生发展是多因素参与的极其复杂的病理过程,因而引起了国内外学者的广泛关注,现就其分子生物学研究进展进行综述。
出处
《中国妇幼保健》
CAS
北大核心
2014年第6期967-969,共3页
Maternal and Child Health Care of China
参考文献3
-
1张娜,吴媛媛,刘海意,龚洵,石鑫玮,李宇琪,乔福元.缺氧对滋养细胞Notch信号通路的影响[J].中国优生与遗传杂志,2012,20(8):15-16. 被引量:3
-
2Li Y Guessous F Zhang Y Dipierro C Kefas B Johnson E Marcinkiewicz L Jiang J Yang Y Schmittgen TD Lopes B Schiff D Purow B Abounader R.MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes[J].中国神经肿瘤杂志,2009,7(4):274-274. 被引量:55
-
3王洪一,郭洪,李娟,白云.mir-34a的表达调控及其与肿瘤发生的关系[J].医学综述,2012,18(7):1020-1023. 被引量:7
二级参考文献36
-
1Lim LP,Lau NC,Garrett-Engele P,et al.Microarray analysis showsthat some microRNAs downregulate large numbers of target mRNAs[J].Nature,2005,433(7027):769-773.
-
2Bommer GT,Gerin I,Feng Y,et al.p53-Mediated activation ofmiRNA34 candidate tumor-suppressor genes[J].Curr Biol,2007,17(15):1298-1307.
-
3Chang TC,Wentzel EA,Kent OA,et al.Transactivation of miR-34aby p53 broadly influences gene expression and promotes apoptosis[J].Mol Cell,2007,26(5):745-752.
-
4He L,He X,Lim LP,et al.A microRNA component of the p53 tumoursuppressor network[J].Nature,2007,447(7148):1130-1134.
-
5Raver-Shapira N,Marciano E,Meiri E,et al.Transcriptional activa-tion of miR-34a contributes to p53-mediated apoptosis[J].MolCell,2007,26(5):731-743.
-
6Tarasov V,Jung P,Verdoodt B,et al.Differential regulation of mi-croRNAs by p53 revealed by massively parallel sequencing:miR-34a is a p53 target that induces apoptosis and G1-arrest[J].CellCycle,2007,6(13):1586-1593.
-
7Welch C,Chen Y,Stallings RL.MicroRNA-34a functions as a po-tential tumor suppressor by inducing apoptosis in neuroblastomacells[J].Oncogene,2007,26(34):5017-5022.
-
8Wei CL,Wu Q,Vega VB,et al.A global map of p53 transcription-factor binding sites in the human genome[J].Cell,2006,124(1):207-219.
-
9Lodygin D,Tarasov V,Epanchintsev A,et al.Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer[J].Cell Cycle,2008,7(16):2591-2600.
-
10Chen X,Hu H,Guan X,et al.CpG island methylation status ofmiRNAs in esophageal squamous cell carcinoma[J].Int J Cancer,2011 May 5.doi:10.1002/ijc.26171.
共引文献61
-
1Xiaoxia Yang,Pengfei Shang,Bingfang Yu,Qiuyang Jin,Jing Liao,Lei Wang,Jianbo Ji,Xiuli Guo.Combination therapy with miR34a and doxorubicin synergistically inhibits Doxresistant breast cancer progression via downregulation of Snail through suppressing Notch/NF-kB and RAS/RAF/MEK/ERK signaling pathway[J].Acta Pharmaceutica Sinica B,2021,11(9):2819-2834. 被引量:9
-
2黄佳圆,王锐,陈龙邦.Notch-1信号通路与肿瘤耐药研究进展[J].医学研究生学报,2011,24(12):1301-1305. 被引量:6
-
3Minal Garg.MicroRNAs,stem cells and cancer stem cells[J].World Journal of Stem Cells,2012,4(7):62-70. 被引量:4
-
4梁朝辉,郭成永,焦保华.胶质瘤及肿瘤干细胞抑制剂—MicroRNA-34a[J].国际神经病学神经外科学杂志,2011,38(3):254-257. 被引量:3
-
5Lin-hui LIANG Xiang-huo HE.Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy[J].Acta Pharmacologica Sinica,2011,32(11):1311-1320. 被引量:6
-
6支枫,王榕,王强,邵耐远,董博,马涛,王穗暖.microRNA与神经胶质瘤的研究进展[J].中华全科医学,2011,9(12):1928-1929. 被引量:2
-
7杨凌云,王红静,贾西彪,王雪,罗娟,张晓燕.miR-130a在卵巢癌顺铂耐药细胞株中的表达及其意义[J].四川大学学报(医学版),2012,43(1):60-64. 被引量:3
-
8王亮,黄凯,刘晓智,李罡,苏治国,王骏飞,赵玉军,刘洪良,陈镭.胶质瘤中miR-34a靶向作用于MAPK13 mRNA并抑制其表达[J].山东医药,2011,51(48):19-21. 被引量:1
-
9姚志勇,张超,马鑫,朱鸣阳,张瑜,史涛平,杨素霞,张旭.microRNA-34a的表达对膀胱癌细胞系J82生物学行为的影响[J].临床泌尿外科杂志,2012,27(1):64-67. 被引量:2
-
10FENG Wei,FENG Yue.MicroRNAs in neural cell development and brain diseases[J].Science China(Life Sciences),2011,54(12):1103-1112. 被引量:20
同被引文献24
-
1李文敏.2种化疗方案治疗绒毛膜癌的经济学评价[J].中国药房,2007,18(23):1769-1770. 被引量:4
-
2Palmer JE,Hancock BW,Tidy JA.Influence of age as a factor in the outcome of gestational trophoblastic neoplasia[J].J Reprod M ed,2008,53(8):565-574.
-
3Salehi S,Eloranta S,Johansson AL,et al.Reporting and incidence trends of hydatidiform mole in Sw eden 1973-2004[J].Acta Oncol,2011,50(3):367-372.
-
4Braun-Parvez L,Charlin E,Caillard S,et al.Gestationalchoriocarcinoma transmission follow ing multiorgan donation[J].Am J Transplant,2010,10(11):2541-2546.
-
5Chalouhi GE,Golfier F,Soignon P,et al.Methotrexate for2000 FIGO low-risk gestational trophoblastic neoplasia patients:efficacy and toxicity[J].Am J Obstet Gynecol,2009,200(6):643,e1-e6.
-
6Bianconi MI,Otero S,Moscheni O,et al.Gestational trophoblastic disease:a 21-year review of the clinical experience at an Argentinean public hospital[J].J Reprod M ed,2012,57(7-8):341-349.
-
7Nagy B,Molnar J,Rovo L,et al.Effective chemoradiotherapy w ithout additive toxicity in locoregionally advanced head and neck cancer[J].Anticancer Res,2003,23(5):4329-4332.
-
8Feng F,Xiang Y.Surgical management of chemotherapy-resistant gestational trophoblastic neoplasia[J].Expert Rev Anticancer,2010,10(1):71-80.
-
9Buza N, Hui P. hnmunohistochemistry and other ancillary techniques in the diagnosis of geslational trophoblastic disea- ses [J].Semin Diagn Pathol, 2014, 31 (3): 223-232.
-
10Ad'inan N, Sait K, Salt H. Gestational trophoblastie disease in the western region of Saudi Arabia ( single-institute experi- ence ) [J]. Eur .JObstet Gyneeol Reprod Biol, 2014, 1 g0 : g - ll.
-
1赵越.子宫腺肌病发病机制的分子生物学研究进展[J].辽宁医学院学报,2010,31(1):89-92. 被引量:11
-
2赵晓霞,董霖.子宫胎盘部位滋养细胞肿瘤1例报告[J].实用医院临床杂志,2008,5(3):38-38.
-
3何艳梅,姚先莹,杨开选.原发于宫颈的胎盘部位滋养细胞肿瘤一例[J].中华病理学杂志,2009,38(9):631-632.
-
4万丽娟,吴楠,尚立新.胎膜早破的分子生物学研究进展[J].医学综述,2012,18(18):2968-2970. 被引量:2
-
5周伟.缺氧缺血性脑损伤的分子生物学研究进展[J].国外医学(儿科学分册),1998,25(1):32-36. 被引量:47
-
6罗欣,漆洪波.子痫前期发病机制分子生物学研究进展[J].中国实用妇科与产科杂志,2012,28(4):309-311. 被引量:45
-
7虞海燕.足月妊娠合并胎盘部位滋养细胞肿瘤3例分析[J].临床医学,2005,25(11):81-81.
-
8于明新,徐丽玲,郭桂芹.胎盘部位滋养细胞肿瘤2例分析[J].中国实用妇科与产科杂志,2000,16(8):480-480.
-
9张蓉,蔡雪珍,林宗跃.胎盘部位滋养细胞肿瘤经阴道超声表现1例[J].临床超声医学杂志,2008,10(6):432-432. 被引量:1
-
10李瑞.胎盘部位滋养细胞肿瘤1例报告[J].中国实用妇科与产科杂志,2011,27(5):393-393.